| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 466,496 | 497,671 | 515,144 | 528,986 | | Cost of Revenue | 192,724 | 196,972 | 208,521 | 206,961 | | | Gross Profit | 273,772 | 300,699 | 306,623 | 322,025 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 9,881 | 8,198 | 12,397 | 10,911 | | Non Recurring |
-
| 11,124 |
-
| 119,303 | | Others | 140,532 | 148,149 | 150,045 | 153,227 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 123,359 | 133,228 | 144,181 | 38,584 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 8,011 | 6,604 | 5,729 | 22,521 | | Earnings Before Interest And Taxes | 131,370 | 139,832 | 149,910 | 61,105 | | Interest Expense | 124,914 | 118,923 | 126,862 | 127,016 | | Income Before Tax | 6,456 | 20,909 | 23,048 | (65,911) | | Income Tax Expense | 457 | 258 | 2,131 | (655) | | Minority Interest | (20,109) |
-
|
-
| 3,256 | | | | Net Income From Continuing Ops | 3,089 | 18,619 | 23,487 | (59,291) | | | Non-recurring Events | | Discontinued Operations | 140,276 | 87,313 | 61,934 | 28,048 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 125,628 | 105,932 | 85,421 | (31,243) | | Preferred Stock And Other Adjustments | 6,734 | (9,347) | (8,246) | (3,620) | | | Net Income Applicable To Common Shares | $132,362 | $96,585 | $77,175 | ($34,863) |
|
0.58% Nasdaq 
Income Statement
